Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
| FUMAFER | |||||
|---|---|---|---|---|---|
| Idem ASCOFER | 100 cp. à 66 mg 50 cp. à 66 mg 50 doses à 33 mg |
2,62 HOP 4,39 |
65 % NR NR |
0,03 0,09 |
|